Dyslipidemia Clinical Trial
NCT number | NCT04004143 |
Other study ID # | QLS2014 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 1, 2013 |
Est. completion date | December 31, 2014 |
Verified date | June 2019 |
Source | Shenzhen Center for Chronic Disease Control |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Adult subjects were recruited from a health examination center. Their fasting blood samples were collected for laboratory analyses of multiple measures including mineral, glucose, lipids, etc.
Status | Completed |
Enrollment | 1520 |
Est. completion date | December 31, 2014 |
Est. primary completion date | November 30, 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 85 Years |
Eligibility |
Inclusion Criteria: - adult volunteer - Han population - living in Shenzhen City for > 2 y Exclusion Criteria: - caught by organic diseases - in pregnancy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shenzhen Center for Chronic Disease Control | Shenzhen Qilinshan Sanatorium, Sun Yat-sen University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | circulation concentration of glucose | Glucose (mmol/L) was measured in less than 4 hours after sample collection | less than 4 hours | |
Primary | circulation concentrations of 4 types of lipids | TG, TC, LDLC, and HDLC (mmol/L) were measured in less than 4 hours after sample collection | less than 4 hours | |
Primary | circulation concentrations of 5 minerals | all samples were stored at minus 75 degrees Celsius until ready for analysis collectively on a ICP-MS machine for calcium, cobalt, iron, selenium, and zinc (ng/ml) | less than 3 years | |
Secondary | body mass index | body weight (kg) and hight (m) were measured when the volunteers were visiting the health examination center, and the body mass index was calculated later by the formula of body weight/ hight/ hight (kg/m^2). | less than 1 month | |
Secondary | circulation concentration of 25OHD | all samples were stored at minus 75 degrees Celsius until ready for analysis collectively with ELISA kits (nmol/L) | less than 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00001154 -
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
|
||
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT02837367 -
Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People
|
N/A | |
Active, not recruiting |
NCT02223793 -
Vascular Lifestyle-Intervention and Screening in Pharmacy
|
N/A | |
Active, not recruiting |
NCT02600338 -
Meta-analyses of the Effect of Legumes on Blood Pressure
|
N/A | |
Completed |
NCT02163044 -
The Hellenic Postprandial Lipemia Study (HPLS)
|
||
Recruiting |
NCT01972113 -
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
|
N/A | |
Recruiting |
NCT01705873 -
Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
|
N/A | |
Completed |
NCT01764295 -
Clinical Study for Patients With Hypertension Associated With Dyslipidemia
|
Phase 3 | |
Terminated |
NCT01414166 -
Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
|
Phase 3 | |
Completed |
NCT01531062 -
Effect of Nigella Sativa on Lipid Profiles in Elderly
|
Phase 2 | |
Completed |
NCT01990391 -
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities
|
N/A | |
Recruiting |
NCT01670968 -
HIV Reverse Cholesterol Transport Study
|
||
Completed |
NCT00977288 -
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
|
Phase 2 | |
Completed |
NCT01285544 -
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
|
Phase 4 | |
Withdrawn |
NCT00664287 -
Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
|
Phase 3 | |
Completed |
NCT00768274 -
Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
|
Phase 1/Phase 2 | |
Completed |
NCT00300430 -
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
|
Phase 3 | |
Completed |
NCT01483235 -
Reduced Cardiac Rehabilitation Program
|
N/A | |
Completed |
NCT00312923 -
Preliminary Study of Safety and Efficacy of Policosanol
|
Phase 2 |